Assessing CRISPR Therapeutics' Valuation As Recent Trading Puts CRSP Back In Focus [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
CRISPR Therapeutics (CRSP) has attracted fresh attention after recent trading left the stock around $54.65, with performance mixed over the past month and past 3 months but stronger over the past year. See our latest analysis for CRISPR Therapeutics. Recent trading has been choppy, with a 1-day share price return of 1.57% decline and a 90-day share price return of 14.84% decline, in contrast with a 1-year total shareholder return of 30.59%. This suggests that longer term momentum remains intact despite shorter term pullbacks. If gene editing is on your radar after looking at CRISPR Therapeutics, it can be worth scanning other healthcare stocks that might fit a similar high-science, high-risk profile. With CRISPR Therapeutics trading near $54.65, showing a 30.59% 1 year return but a 14.84% 90 day decline, and sitting at a large implied discount to some valuation estimates, is there genuine upside left or is the market already pricing in future growth? CRISPR Therapeutics tra
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- BofA is Bullish on CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics (CRSP) Still Attractive After A 67% Five Year Share Price Decline [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Bank of America Corporation from $90.00 to $89.00. They now have a "buy" rating on the stock.MarketBeat
- CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Crispr Therapeutics: Patience And Opportunity Through Volatility [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 1/27/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 4
- CRSP's page on the SEC website